Guideline-Directed Medical Therapy After Revascularization and Outcomes in Ischaemic Cardiomyopathy
GDMTi was associated with lower unadjusted mortality, though not significant after adjustment. GDMTi combined with CABG showed the best outcomes. The use of GDMTi improved over time.
Authors
- Antoni Bayés‐Genís (ORCID: https://orcid.org/0000-0002-3044-197X)
- Régis Olivès (ORCID: https://orcid.org/0000-0003-0369-6712)
- Eduard Solé‐González (ORCID: https://orcid.org/0000-0002-5727-9925)
- Dabit Arzamendi Aizpurua
- Manel Taurón Ferrer
- P. M. Gonzalez Castillo (ORCID: https://orcid.org/0000-0002-3684-7348)
- Juan Carlos de la Fuente Mancera (ORCID: https://orcid.org/0000-0001-9770-4626)
- Maria Calvo‐Barceló (ORCID: https://orcid.org/0009-0007-7069-1213)
- Carlos Moliner‐Abós (ORCID: https://orcid.org/0000-0002-9264-5804)
- Pau Vilardell (ORCID: https://orcid.org/0000-0003-4033-2862)
- María Ferré Vallverdú (ORCID: https://orcid.org/0000-0002-1489-9438)
- Ignacio Ferreira González (ORCID: https://orcid.org/0000-0003-3663-3259)
- Carles Díez‐López (ORCID: https://orcid.org/0000-0002-3734-4777)
- J. David Vega (ORCID: https://orcid.org/0000-0002-0101-1962)
- Joan Vime Jubany
- Sònia Mirabet Pérez
- Andrea Borrellas Martín
- Paula Fluvià Brugués
Institutions
- Universitat Autònoma de Barcelona (ES)
- Hospital de Sant Pau (ES)
- Bellvitge University Hospital (ES)
- Institut d'Investigació Biomèdica de Girona (ES)
- Hospital Clínic de Barcelona (ES)
- Vall d'Hebron Hospital Universitari (ES)
- Hospital Universitari Sant Joan de Reus (ES)
- Hospital Universitari Germans Trias i Pujol (ES)
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES)
- Hospital Universitari de Girona Doctor Josep Trueta (ES)
Publication Details
- Journal
- ESC Heart Failure
- Published
- 2025-11-17
- DOI
- https://doi.org/10.1002/ehf2.70014
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministerio de Economía y Competitividad
- Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares
- Instituto de Salud Carlos III
- European Regional Development Fund